Peo in Interest of Parrett ( 2024 )


Menu:
  • 24CA0911 Peo in Interest of Parrett 07-18-2024
    COLORADO COURT OF APPEALS
    Court of Appeals No. 24CA0911
    Pueblo County District Court No. 24MH30023
    Honorable Timothy O’Shea, Judge
    The People of the State of Colorado,
    Petitioner-Appellee,
    In the Interest of Bradley Kenneth Parrett,
    Respondent-Appellant.
    ORDER AFFIRMED
    Division VI
    Opinion by JUDGE SCHUTZ
    Freyre and Lipinsky, JJ., concur
    NOT PUBLISHED PURSUANT TO C.A.R. 35(e)
    Announced July 18, 2024
    Cynthia Mitchell, County Attorney, Kate H. Shafer, Special Assistant County
    Attorney, Pueblo, Colorado, for Petitioner-Appellee
    Tezak Law, P.C., Mary Tezak, Florence, Colorado, for Respondent-Appellant
    1
    ¶ 1 Respondent, Bradley Kenneth Parrett, appeals the district
    court’s order authorizing the staff at the Colorado Mental Health
    Hospital in Pueblo (CMHHIP) to involuntarily administer
    medication. We affirm.
    I. Background
    ¶ 2 Parrett was committed to CMHHIP for competency restoration
    in a criminal case. When Parrett arrived at CMHHIP in November
    2023, he was irritable, exhibited thought blocking and disorganized
    thinking, and expressed paranoid delusions. Over time, Parrett’s
    condition deteriorated, and he became physically aggressive. His
    physical aggression progressed over time: (1) on March 15, without
    provocation, he pushed a peer from behind; (2) on April 8, he made
    threatening statements to staff; and (3) on April 24, he hit a peer
    with his fists. The medical staff started him on emergency
    medication after the last incident.
    ¶ 3 Dr. Paul Mattox, a staff psychiatrist at CMHHIP and Parrett’s
    attending psychiatrist, diagnosed Parrett with schizophrenia and
    sought to treat him with Olanzapine (Zyprexa), but Parrett refused
    to take this medication voluntarily. On May 7, 2024, the People
    2
    filed a motion seeking a court order to authorize the involuntary
    administration of the medication.
    ¶ 4 The district court held a hearing on May 13, 2024. Dr. Mattox
    testified for the People and Parrett testified on his own behalf. At
    the end of the hearing, the court concluded that the People had
    proved all four elements set forth in People v. Medina, 705 P.2d 961
    (Colo. 1985), and issued an order allowing CMHHIP staff to
    administer the requested medication to Parrett against his will.
    II. Discussion
    ¶ 5 Parrett contends that the evidence presented to the district
    court was insufficient to support the involuntary medication order.
    While he concedes that sufficient evidence supports the first,
    second, and third Medina factors, he asserts there was insufficient
    evidence to establish the fourth factor. We are not persuaded.
    A. Applicable Law and Standard of Review
    ¶ 6 An involuntarily committed or legally incompetent person
    retains the right to refuse treatment. Id. at 971. But a district
    court may order that a patient be involuntarily administered
    medications if the People prove, by clear and convincing evidence,
    the four factors outlined in Medina:
    3
    (1) the patient is incompetent to effectively
    participate in the treatment decision;
    (2) treatment by antipsychotic and other
    medications is necessary to prevent a
    significant and likely long-term deterioration in
    the patient’s mental condition, or to prevent
    the likelihood of the patient causing serious
    harm to himself or others in the institution;
    (3) a less intrusive treatment alternative is not
    available; and
    (4) the patient’s need for treatment by
    antipsychotic and other medications is
    sufficiently compelling to override any bona
    fide and legitimate interest he or she has in
    refusing treatment.
    Id. at 973.
    ¶ 7 The State must prove each Medina factor by clear and
    convincing evidence. People in Interest of R.K.L., 2016 COA 84,
    30. A treating physician’s testimony may be sufficient to satisfy
    the State’s burden of proof. See People v. Pflugbeil, 834 P.2d 843,
    847 (Colo. App. 1992).
    ¶ 8 Where, as here, a patient challenges the sufficiency of the
    evidence supporting the district court’s finding on any of these
    elements, we review the court’s conclusions of law de novo and
    defer to its factual findings if supported by the evidence. People v.
    Marquardt, 2016 CO 4, ¶ 8. We view the evidence as a whole and in
    4
    the light most favorable to the People, leaving the resolution of
    conflicts in the testimony and determinations of witness credibility
    solely to the fact finder. People v. Fuentes, 258 P.3d 320, 326 (Colo.
    App. 2011). Where “ample evidence in the record . . . support[s] the
    trial court’s findings and conclusion[s], based on clear and
    convincing evidence,” we may not “substitute[] [our] judgment for
    that of the trial court.” People in Interest of A.J.L., 243 P.3d 244,
    255 (Colo. 2010).
    B. Analysis
    ¶ 9 To satisfy the fourth Medina factor, a court must determine
    whether the patient’s refusal is bona fide and legitimate. Medina,
    705 P.2d at 974. If so, the court must then determine “whether the
    prognosis without treatment is so unfavorable that the patient’s
    personal preference must yield to the legitimate interests of the
    state in preserving the life and health of the patient placed in its
    charge and in protecting the safety of those in the institution.Id.
    ¶ 10 The district court found that Parrett had a bona fide and
    legitimate interest in refusing treatment based on his religion
    (which prohibits him from taking pharmaceuticals because they are
    considered poison) and his preference for natural medications.
    5
    However, the court also found that Parrett’s “prognosis [was] so
    unfavorable that his bona fide and legitimate interest for refusing
    medication must yield to the legitimate interest the State has in
    preserving his life and health and protecting [the] safety of those in
    the institution.” The record supports these findings.
    ¶ 11 During the hearing, Parrett’s attorney asked him, “Do you
    have any religious, cultural, or background beliefs that preclude
    you from taking pharmaceuticals or Zyprexa specifically?” Parrett
    responded, “I would be given the tithing as a Messianic Jew, a
    Jewish Christian, a Christian that there are other diasporas,
    scattered seeds, sections of such religion. Such teachings of which
    are given through holy scripture has given me means to search as
    for what pharmaceuticals are.” Parrett’s counsel followed up by
    asking, “If you would just explain how your religious belief
    precludes you from taking medication?” Parrett responded,
    I would come to search for knowledge for the
    correct path of which man may walk. That is
    where we come to believe knowledge that is
    given to us. And with this knowledge that is
    given how we come and decide to walk in the
    paths that we would take.
    6
    On cross-examination, Parrett added that he refuses “poison, not
    medicine” and, according to him, Zyprexa is poison because it is a
    pharmaceutical.
    ¶ 12 Dr. Mattox testified that Zyprexa has adverse side effects, but
    that the failure to medicate Parrett would be more harmful than the
    risks that Zyprexa posed. Dr. Mattox noted his concerns (which
    were based on his clinical observations of Parrett) that, without
    Zyprexa Parrett would again deteriorate and become assaultive. He
    testified that, while he is aware Parrett has “made references to
    wanting to take something natural, but Dr. Mattox was not able to
    really understand precisely what that means or what his objections
    are for medications and if those objections are grounded in rational
    thought.” Moreover, Dr. Mattox testified that he was not aware of a
    natural supplement or medicine that has been shown to be effective
    at treating Parrett’s symptoms. And he testified that, while Parrett
    had not observed or reported any side effects since he started
    taking Zyprexa, the medical staff would continue to monitor him for
    side effects.
    7
    ¶ 13 The district court found Dr. Mattox’s testimony credible and
    persuasive, and his testimony was sufficient to support the court’s
    findings on the fourth Medina factor.
    ¶ 14 Nevertheless, Parrett asserts that, because the district court
    was unable to ascertain the connection between Parrett’s religious
    beliefs and his refusal of treatment describing his statements on
    the topic as “non sequiturs” — the court was unable to properly
    weigh them against the State’s interest in forcibly medicating him.
    But the district court considered Parrett’s religious views and
    preference for natural medications and treated them as bona fide
    and legitimate. Any lack of understanding on the court’s part was
    based on Parrett’s nonresponsive and incongruous answers to his
    counsel’s questions regarding the nature of his religious objections.
    And given this testimony, we cannot say the court erred by
    concluding that Parrett’s danger to himself or others outweighed his
    religious beliefs. See Medina, 705 P.2d at 974. (While the “patient’s
    refusal may stem from . . . an absolute and unequivocal religious
    belief or practice,” the court must nevertheless “determine whether
    the patient’s refusal is bona fide and legitimate” and weigh the
    patient’s preference with the “legitimate interests of the state in
    8
    preserving the life and health of the patient placed in its charge and
    in protecting the safety of those in the institution.”).
    ¶ 15 Because the record supports the district court’s findings, we
    conclude that it did not err by finding that any desire Parrett might
    have in refusing medication was overridden by his sufficiently
    compelling need for treatment. See R.K.L., ¶¶ 13, 30.
    III. Disposition
    ¶ 16 The order is affirmed.
    JUDGE FREYRE and JUDGE LIPINSKY concur.

Document Info

Docket Number: 24CA0911

Filed Date: 7/18/2024

Precedential Status: Precedential

Modified Date: 7/22/2024